Takeda - Top 10 Layoffs of 2010

Company: Takeda
Layoffs: 1,400

Scoop: As Takeda prepares for diabetes drug Actos' patent expiration, it announced 1,400 jobs cut within the U.S. "The business environment for the pharmaceutical industry is changing dramatically," the company says in a statement, "with the pharmaceutical industry as a whole facing barriers to technological innovation that have halted progress in breakthrough novel drugs, stricter approval processes for new drugs in advanced nations, and radical upheaval in healthcare systems."

The cuts came primarily from Takeda's U.S. headquarters in Deerfield, IL and the Takeda Global Research and Development Center.

Takeda - Top 10 Layoffs of 2010
Read more on

Suggested Articles

It’s been a rocky road for BMS’ immuno-oncology duo in previously untreated lung cancer, but a new addition to the regimen might hold the ticket.

Novartis’ Zolgensma launch has been anything but boring: First a record price, then a data scandal and now a manufacturing-related delay in Europe.

As CEO Paul Hudson focuses Sanofi's R&D program on immuno-oncology and gene therapies, Sanofi is readying a vaccine plant to make viral vectors.